UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study

BMC infectious diseases, 2021-12, Vol.21 (1), p.1277-9, Article 1277

2021

Volltextzugriff (PDF)

Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma

Terapevtic̆eskii arhiv, 2020-12, Vol.92 (12), p.172-179

2020

Volltextzugriff (PDF)

Development of Instruments for Audit Quality Assessment and Control

Učët. Analiz. Audit (Online), 2019-10, Vol.6 (5), p.58-68

Fomina, D. S.

2019

Volltextzugriff (PDF)

Significance of individual management plan for the patients with hereditary lymphangioedema during pregnancy and lactation, and in newborns

Medit͡s︡inskai͡a︡ immunologii͡a, 2020-05, Vol.22 (3), p.577-584

2020

Volltextzugriff (PDF)

Baricitinib in the Treatment of Patients with COVID-19: A Review of International Data and Analysis of Clinical Results in the Russian Population

Antibiotics and Chemotherapy, 2021-05, Vol.66 (1-2), p.47-56

2021

Volltextzugriff (PDF)

Common variable immune deficiency in adults: focus on pulmonary complications

Terapevtic̆eskii arhiv, 2017, Vol.89 (12-2), p.211-215

2017

Volltextzugriff (PDF)

Photoplethysmography as a New Tool for Dermographism Quantitive Evaluation

2024 Wave Electronics and its Application in Information and Telecommunication Systems (WECONF), 2024, p.1-4

2024

Volltextzugriff (PDF)

The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting

Terapevtic̆eskii arhiv, 2022-12, Vol.94 (11), p.1294-1302

2022

Volltextzugriff (PDF)

Routing principles for patients with hereditary angioedema

Rossiĭskiĭ vestnik perinatologii i pediatrii, 2021-07, Vol.66 (3), p.94-101

2021

Volltextzugriff (PDF)

Efficacy of dupilumab in real practice in the treatment of severe forms of asthma and atopic dermatitis (comparative retrospective study)

Terapevtic̆eskii arhiv, 2023-09, Vol.95 (7), p.568-573

2023

Volltextzugriff (PDF)

The burden of COVID-19 in a heterogeneous population of immunocompromised patients – realities of the postpandemic

Terapevtic̆eskii arhiv, 2023-10, Vol.95 (8), p.722-729

2023

Volltextzugriff (PDF)

Bronchial asthma and the vitamin D deficiency

Clinical Medicine (Russian Journal), 2018-12, Vol.96 (7), p.590-596

2018

Volltextzugriff (PDF)

Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study

Terapevtic̆eskii arhiv, 2023-08, Vol.95 (6), p.494-499

2023

Volltextzugriff (PDF)

Efficacy of benralizumab in severe eosinophilic asthma: results of a real clinical practice prospective study BEST in Russia

Pulʹmonologii͡a︡ (Moscow, Russia), 2024-05, Vol.34 (3), p.441-453

2024

Volltextzugriff (PDF)

To the problem of somatic-hypochondriac paranoia

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2023, Vol.123 (4. Vyp. 2), p.6

2023

Volltextzugriff (PDF)

Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies

Terapevtic̆eskii arhiv, 2023-02, Vol.95 (1), p.78-84

2023

Volltextzugriff (PDF)

Analysis of predictors of response to anti-IgE therapy in patients with severe atopic bronchial asthma in real clinical practice

Terapevtic̆eskii arhiv, 2022-03, Vol.94 (3), p.413-419

2022

Volltextzugriff (PDF)

Efficacy of olokizumab in patients with mild or moderate COVID-19 and risk factors of progression

Pulʹmonologii͡a︡ (Moscow, Russia), 2023-09, Vol.33 (5), p.623-632

2023

Volltextzugriff (PDF)

Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit

Terapevtic̆eskii arhiv, 2022-06, Vol.94 (5), p.675-682

2022

Volltextzugriff (PDF)

Efficacy of benralizumab in severe eosinophilic asthma: an interim analysis of a real clinical practice prospective study BEST in Russia

Pulʹmonologii͡a︡ (Moscow, Russia), 2023-06, Vol.33 (3), p.374-385

2023

Volltextzugriff (PDF)

Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19

Terapevtic̆eskii arhiv, 2021-11, Vol.93 (11), p.1316-1324

2021

Volltextzugriff (PDF)

Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients’ treatment

Terapevtic̆eskii arhiv, 2022-06, Vol.94 (5), p.668-674

2022

Volltextzugriff (PDF)

Problems and opportunities to improve diagnosis of asthma and chronic obstructive pulmonary disease in Russia: resolution of advisory board

Terapevtic̆eskii arhiv, 2022-05, Vol.94 (4), p.524-529

2022

Volltextzugriff (PDF)

Cardiac damage in patients with COVID-19 coronavirus infection

"Arterial’naya Gipertenziya" ("Arterial Hypertension"), 2020-06, Vol.26 (3), p.277-287

2020

Volltextzugriff (PDF)

Federal guidelines on diagnosis and treatment of bronchial asthma

Pulʹmonologii͡a︡ (Moscow, Russia), 2022-07, Vol.32 (3), p.393-447

2022

Volltextzugriff (PDF)

1 – 25 von 698

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(602)
Mit Volltextzugriff
(382)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study

Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma

Development of Instruments for Audit Quality Assessment and Control

Significance of individual management plan for the patients with hereditary lymphangioedema during pregnancy and lactation, and in newborns

Baricitinib in the Treatment of Patients with COVID-19: A Review of International Data and Analysis of Clinical Results in the Russian Population

Common variable immune deficiency in adults: focus on pulmonary complications

Photoplethysmography as a New Tool for Dermographism Quantitive Evaluation

The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting

Routing principles for patients with hereditary angioedema

Efficacy of dupilumab in real practice in the treatment of severe forms of asthma and atopic dermatitis (comparative retrospective study)

The burden of COVID-19 in a heterogeneous population of immunocompromised patients – realities of the postpandemic

Bronchial asthma and the vitamin D deficiency

Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study

Efficacy of benralizumab in severe eosinophilic asthma: results of a real clinical practice prospective study BEST in Russia

To the problem of somatic-hypochondriac paranoia

Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies

Analysis of predictors of response to anti-IgE therapy in patients with severe atopic bronchial asthma in real clinical practice

Efficacy of olokizumab in patients with mild or moderate COVID-19 and risk factors of progression

Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit

Efficacy of benralizumab in severe eosinophilic asthma: an interim analysis of a real clinical practice prospective study BEST in Russia

Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19

Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients’ treatment

Problems and opportunities to improve diagnosis of asthma and chronic obstructive pulmonary disease in Russia: resolution of advisory board

Cardiac damage in patients with COVID-19 coronavirus infection

Federal guidelines on diagnosis and treatment of bronchial asthma

Suchergebnisse filtern